Gene expressed in prostate cancer

Details for Australian Patent Application No. 2003259622 (hide)

Owner Agensys, Inc.

Inventors Mitchell, Stephen Chappell; Hubert, Rene S.; Afar, Daniel E.

Agent FB Rice

Pub. Number AU-B-2003259622

Parent 764096

Filing date 3 November 2003

Wipo publication date 20 November 2003

Acceptance publication date 6 July 2006

International Classifications

C12N 15/12 (2006.01) Mutation or genetic engineering - Genes encoding animal proteins

A61K 39/00 (2006.01) Medicinal preparations containing antigens or antibodies

C07K 14/47 (2006.01) Peptides having more than 20 amino acids

Event Publications

13 November 2003 Complete Application Filed

20 November 2003 Application Open to Public Inspection

  Published as AU-B-2003259622

6 July 2006 Application Accepted

  Published as AU-B-2003259622

2 November 2006 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003259623-Liquid carbondioxide vapour shooter truck fire extinguisher

2003259621-Tumor Necrosis Factor Receptors 6alpha and 6beta